Conversion Surgery with HIPEC for Peritoneal Oligometastatic Gastric Cancer

Conversion Surgery with HIPEC for Peritoneal Oligometastatic Gastric Cancer

Peritoneal metastases (PM) of gastric cancer (GC) are characterized by a particularly poor prognosis, with median survival time of 6 months, and virtually no 5-year survival reported. Conversion therapy for GC is defined as a surgical treatment aiming at an R0 resection after systemic chemotherapy f...

Full description

Bibliographic Details
Main Authors: Jerzy Mielko, Karol Rawicz-Pruszyński, Magdalena Skórzewska, Bogumiła Ciseł, Agnieszka Pikuła, Magdalena Kwietniewska, Katarzyna Gęca, Katarzyna Sędłak, Andrzej Kurylcio, Wojciech P. Polkowski
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cancers
Subjects:
gastric cancer
peritoneal metastases
conversion therapy
crs
hipec
Online Access:https://www.mdpi.com/2072-6694/11/11/1715

Internet

https://www.mdpi.com/2072-6694/11/11/1715

Similar Items